INTS
Intensity Therapeutics, Inc. Common stock
NASDAQ: INTS · HEALTHCARE · BIOTECHNOLOGY
$5.21
+0.06% today
Updated 2026-05-06
Market cap
$13.80M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-8.56
Dividend yield
—
52W range
$5 – $44
Volume
0.0M
Intensity Therapeutics, Inc. Common stock (INTS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-156.90%
ROA
-79.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-5.23M | — | — | — |
| 2020 | $0.00 | $-5.96M | — | — | — |
| 2021 | $0.00 | $-7.89M | — | — | — |
| 2022 | $0.00 | $-7.58M | — | — | — |
| 2023 | $0.00 | $-10.54M | — | — | — |
| 2024 | $0.00 | $-16.27M | — | — | — |
| 2025 | $0.00 | $-11.61M | — | — | — |